A designed cyclic peptide based on Trastuzumab used to construct peptide-drug conjugates for its HER2-targeting ability
Jiaqi Zhou, Yuxing Zou, Yan Cai, Fanglian Chi, Wenlong Huang, Wei Shi, Hai Qian
Topics & Concepts
ConjugateCamptothecinTrastuzumabChemistryPeptideMonoclonal antibodyAntibody-drug conjugateOligopeptidePharmacologyAntibodyIn silicoCancer researchBiochemistryCancerBiologyImmunologyMedicineInternal medicineBreast cancerMathematicsGeneMathematical analysisMonoclonal and Polyclonal Antibodies ResearchHER2/EGFR in Cancer ResearchPeptidase Inhibition and Analysis